CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Network Study Title CIRB
NRG-CC005 NRG FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps) Cancer Prevention and Control CIRB
NRG-CC006 NRG A Survey Study to Evaluate Physician Attitudes and Perceptions Regarding a Non-Surgical Approach to Breast Cancer Treatment Cancer Prevention and Control CIRB
NRG-CC007CD NRG Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy Cancer Prevention and Control CIRB
NRG-CC008 NRG A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk] Cancer Prevention and Control CIRB
NRG-CC009 NRG Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer Cancer Prevention and Control CIRB
NRG-CC010 NRG A Phase III Trial of the Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Endometrial Cancer Cancer Prevention and Control CIRB
NRG-CC011 NRG Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial Cancer Prevention and Control CIRB
NRG-CC012CD NRG Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment (SYMON) Cancer Prevention and Control CIRB
NRG-CC013 NRG A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation Cancer Prevention and Control CIRB
NRG-CC014 NRG Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT) Cancer Prevention and Control CIRB